Can a listening ear improve cancer care? new study tests support coordinator model
NCT ID NCT07428655
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a trained Patient Support Coordinator (PSC) can help women with advanced breast cancer feel more heard and understood. Over three months, 28 participants will have regular supportive listening sessions alongside their usual medical care. The goal is to see if this model is acceptable and feasible in a busy cancer center.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Patient Support Coordinator (PSC)-facilitated supportive listening sessions
- What this could lead to
- If successful, this model could provide a simple, non-clinical way to help patients feel heard and understood during cancer care.
- What could go wrong
- This is a very small pilot study with only 28 participants and no control group, so results may not apply broadly. The intervention is supportive, not curative.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
28 people
The number who actually took part.
- Started
-
Aug 2025
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of advanced cancer (Stage III or IV) or assessed to be at risk of recurrence by treating oncologist * Aware of cancer diagnosis * Proficiency in English or Mandarin Exclusion Criteria: * Cognitive impairment preventing provision of informed consent * Poorly controlled mental health conditions
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Centre Singapore
Singapore, 168583, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo outsmart breast cancer that resists current therapy?
- Can a new tracer make tumors light up on scans?
- Can fasting and exercise beat cancer fatigue?
- CBD as a calming agent for Scan-Related anxiety in advanced breast cancer?
- Can a new pill tame advanced breast cancer?
- Can a Two-Step drug combo outsmart advanced HER2-Positive breast cancer?